PreprintLicence Ouverte 2.0HAL
Optimal Control of Vaccine Therapy in a Tumor-Immune-Vaccine Model for Pituitary Neuroendocrine Tumors
Related
- Cell-type-specific localization of huntingtin-associated protein 1 in neuroendocrine and neurosecretory systems of the mouse hypothalamic–pituitary axis
- Modeling, Analysis, and Optimal Control of Leukemic Cell Population Dynamics Under Therapy
- Oral artificial microbio-vaccine triggers synergistic immunogenic cell death induction and tumor microenvironment remodeling for liver cancer therapy.
- CXCR3 on transferred T cells enables vaccine-boosted adoptive T-cell therapy in solid tumors
- Unraveling the use of vaccine therapy in HER2-positive breast cancer: a comprehensive review of current state and future perspectives
BibTeX
@misc{lassounon2026optimal,
title = {{Optimal Control of Vaccine Therapy in a Tumor-Immune-Vaccine Model for Pituitary Neuroendocrine Tumors}},
author = {Enagnon David Lassounon and Mahouton Lazare Hounvènou},
howpublished = {HAL},
year = {2026},
month = sep,
url = {https://hal.science/hal-05732977v2},
}
RIS
TY - UNPB
TI - Optimal Control of Vaccine Therapy in a Tumor-Immune-Vaccine Model for Pituitary Neuroendocrine Tumors
AU - Enagnon David Lassounon
AU - Mahouton Lazare Hounvènou
PY - 2026
DA - 2026/09/05
PB - HAL
UR - https://hal.science/hal-05732977v2
ER -